The supertred indicator triggered a buy on 6th July 2022 on the daily charts. The stock moved in a tight band of 150 points where 1420 acted as a stiff resistance while on the downside 1280-1300 acted as a support.The stock broke out from the said pattern earlier in August and is sustaining above the support line which is a positive sign.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418